[16] [17] Early appetite changes represent the initial pharmacological effect, while measurable weight reduction reflects the cumulative impact of sustained caloric deficit over time
For typical GERD symptoms without alarm features, an 8-week trial of a once-daily proton pump inhibitor (PPI) such as omeprazole or esomeprazole is recommended, taken 30-60 minutes before breakfast
Over a period of 12 weeks, patients will be guided with recipe ideas, tips, tasks and engaging content sent from you
Conclusion The STEP 5 trial evaluated the effectiveness and safety of weekly subcutaneous semaglutide 2.4 mg compared to placebo, both alongside behavioral intervention, for the long-term management of adults dealing with obesity or overweight along with at least one weight-related comorbidity, excluding diabetes
It is a genuine obstacle to treatment